eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
.
.
.
meet other global citizens who care about the same issues you do. keep updated on what they're doing to change the world.
.
mitchell: i think frozen is great because sometimes with fresh food, it goes bad.
.